Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib in Patients With Cirrhosis, Portal Hypertension, and HCC
NCT01714609Phase 2Completed
- Sponsor
- Yale University
- Start
- Aug 2011
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in Portal Hypertension (PH), sponsored by Yale University. Started Aug 2011; status: completed.
02
Drugs
sorafenib
03
Conditions
Portal Hypertension (PH)
Beyond the preview
Go deeper on NCT01714609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01714609.